Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: A meta-analysis

Clinical Therapeutics

Volumn 22, Issue 3, 2000, Pages 351-358

  Ross, Robert N ^a   Nelson, Harold S ^b   Finegold, Ira ^c  

^a Medical/Science Analytics   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Allergy; Bee sting; Immunotherapy; Insect venom; Meta analysis

Indexed keywords

HYMENOPTERA VENOM;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; DATA BASE; DESENSITIZATION; HONEYBEE; HUMAN; HYPERSENSITIVITY REACTION; IMMUNOTHERAPY; INFLAMMATION; INSECT STING; MAJOR CLINICAL STUDY; META ANALYSIS; TREATMENT OUTCOME;

EID: 0033996145     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80039-9     Document Type: Article

References (23)

1. 1. Golden DB, March DG, Freidhoff LR, et al. Natural history of Hymenoptera venom sensitivity in adults. J Allergy Clin Immunol. 1997;100:760-766.
2. 2. Novembre E, Cianferoni A, Bernardini R, et al. Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features. Clin Exp Allergy. 1998;28:834-838.
3. 3. Schäfer T, Przybilla B. IgE antibodies to Hymenoptera venom in the serum are common in the general population and are related to indications of atopy. Allergy. 1996;51:372-377.
4. 4. Norman PS. Immunotherapy for nasal allergy. J Allergy Clin Immunol. 1988;81: 992-996.
5. 5. Weber RW. Immunotherapy with allergens. JAMA. 1997;278:1881-1887.
6. 6. Vervloet D, van der Brempt X, Charpin D, Birnbaum J. Immunotherapy in allergic respiratory diseases. Lung. 1990;168 (Suppl):1013-1024.
7. 7. Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299:157-161.
8. 8. Tsicopoulos A, Tonnel AB, Wallaert B, et al. Decrease of IgE-dependent platelet activation in Hymenoptera hypersensitivity after specific rush desensitization. Clin Exp Immunol. 1988;71:433-438.
9. 9. Schuberth KC, Lichtenstein LM, Kagey-Sobotka A, et al. Epidemiologic study of insect allergy in children. II. Effect of accidental stings in allergic children. J Pediatr. 1983;102:361-365.
10. 10. Graft DF, Schuberth KC, Kagey-Sobotka A, et al. The development of negative skin tests in children treated with venom immunotherapy. J Allergy Clin Immunol. 1984:73:61-68.
11. 11. Wyss M, Scheitlin T, Stadler BM, Wuthrich B. Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): Immunologic and clinical results of a prospective study over 3 years. Allergy. 1993;48:81-86.
12. 12. Yunginger JW, Paull BR, Jones RT, Santrach PJ. Rush venom immunotherapy program for honeybee sting sensitivity. J Allergy Clin Immunol. 1979;63:340-347.
13. 13. Thurnheer U, Muller U, Stoller R, et al. Venom immunotherapy in Hymenoptera sting allergy: Comparison of rush and conventional hyposensitization and observations during long-term treatment. Allergy. 1983;38:465-475.
14. 14. Muller U, Thurnheer U, Patrizzi R, et al. Immunotherapy in bee sting hypersensitivity: Bee venom versus whole-body extract. Allergy. 1979;34:369-378.
15. 15. Jarisch R. Spezifische Immuntherapie. Padiatr Padol. 1990;25:405-407.
16. 16. Adamek-Guzik T. Nadwra.ANG.zliwosc na jad pszczeli. Przegl Lek. 1994;51:161-166.
17. 17. Golden DB, Kwiterovich KA, Kagey-Sobotka A, et al. Discontinuing venom immunotherapy: Outcome after five years. J Allergy Clin Immunol. 1996;97:579-587.
18. 18. Tamir R, Levy I, Duer S, Pick AI. Immediate adverse reactions to immunotherapy in allergy. Allergy. 1992;47:260-263.
19. 19. Cappelleri JC, Ioannidis JPA, Schmid CH, et al. Large trials vs meta-analysis of smaller trials: How do their results compare? JAMA. 1996;276:1332-1338.
20. 20. LeLorier J, Grégoire G, Benhaddad A, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med. 1997:337:536-542.
21. 21. Golden DBK, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Prolonged maintenance interval in Hymenoptera venom immunotherapy. J Allergy Clin Immunol. 1981:67:482-484.
22. 22. Reisman RE. Duration of venom immunotherapy: Relationship to the severity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol. 1993; 92:831-836.
23. 23. Bousquet J, Velasquez G, Michel F-B. Evolution of sensitivity to Hymenoptera venoms during maintenance immunotherapy. Allergy Proc. 1989;10:115-118.